OBJECTIVE: We evaluated behavior problems in children who were prenatally exposed to methamphetamine (MA) at ages 3 and 5 years. METHODS: The Infant Development, Environment, and Lifestyle study, a prospective, longitudinal study of prenatal MA exposure and child outcome, enrolled subjects postpartum in Los Angeles, California; Honolulu, Hawaii; Des Moines, Iowa; and Tulsa, Oklahoma. Prenatal exposure was determined by maternal self-report and/or meconium results. Exposed and comparison groups were matched on race, birth weight, public health insurance, and education. Mothers in the comparison group denied use and had a negative meconium screen for amphetamines. Prenatal exposures to tobacco, alcohol, or marijuana occurred in both groups. At ages 3 and 5 years, 330 children (166 exposed and 164 comparison) were assessed for behavior problems by using the caregiver report on the Child Behavior Checklist. General linear mixed models were used to determine the effects of prenatal MA exposure, including heavy exposure (≥3 days per week), age, and the interaction of exposure and age on behavior problems with adjustment for other drugs of abuse and environmental risk factors. RESULTS: MA exposure was associated with increased emotional reactivity and anxious/depressed problems at both ages and externalizing and attention-deficit/hyperactivity disorder problems by age 5 years. Heavy exposure was related to attention problems and withdrawn behavior at both ages. There were no effects of MA on the internalizing or total behavior problems scales. CONCLUSIONS: This first report of behavior problems in patients as young as 3 years associated with MA exposure identifies an important public health problem. Continued follow-up can inform the development of preventive intervention programs.
OBJECTIVE: We evaluated behavior problems in children who were prenatally exposed to methamphetamine (MA) at ages 3 and 5 years. METHODS: The Infant Development, Environment, and Lifestyle study, a prospective, longitudinal study of prenatal MA exposure and child outcome, enrolled subjects postpartum in Los Angeles, California; Honolulu, Hawaii; Des Moines, Iowa; and Tulsa, Oklahoma. Prenatal exposure was determined by maternal self-report and/or meconium results. Exposed and comparison groups were matched on race, birth weight, public health insurance, and education. Mothers in the comparison group denied use and had a negative meconium screen for amphetamines. Prenatal exposures to tobacco, alcohol, or marijuana occurred in both groups. At ages 3 and 5 years, 330 children (166 exposed and 164 comparison) were assessed for behavior problems by using the caregiver report on the Child Behavior Checklist. General linear mixed models were used to determine the effects of prenatal MA exposure, including heavy exposure (≥3 days per week), age, and the interaction of exposure and age on behavior problems with adjustment for other drugs of abuse and environmental risk factors. RESULTS: MA exposure was associated with increased emotional reactivity and anxious/depressed problems at both ages and externalizing and attention-deficit/hyperactivity disorder problems by age 5 years. Heavy exposure was related to attention problems and withdrawn behavior at both ages. There were no effects of MA on the internalizing or total behavior problems scales. CONCLUSIONS: This first report of behavior problems in patients as young as 3 years associated with MA exposure identifies an important public health problem. Continued follow-up can inform the development of preventive intervention programs.
Authors: Joni Reef; Inge van Meurs; Frank C Verhulst; Jan van der Ende Journal: J Am Acad Child Adolesc Psychiatry Date: 2010-09-27 Impact factor: 8.829
Authors: Diana Nguyen; Lynne M Smith; Linda L Lagasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry M Lester Journal: J Pediatr Date: 2010-06-08 Impact factor: 4.406
Authors: Barry M Lester; Edward Z Tronick; Linda LaGasse; Ronald Seifer; Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Linda L Wright; Vincent L Smeriglio; Jing Lu; Loretta P Finnegan; Penelope L Maza Journal: Pediatrics Date: 2002-12 Impact factor: 7.124
Authors: Luciana Anselmi; Fernando C Barros; Maycoln L M Teodoro; César A Piccinini; Ana Maria B Menezes; Cora L Araujo; Luis A Rohde Journal: J Child Psychol Psychiatry Date: 2008-03-10 Impact factor: 8.982
Authors: Maja A Kwiatkowski; Annerine Roos; Dan J Stein; Kevin G F Thomas; Kirsty Donald Journal: Metab Brain Dis Date: 2013-12-28 Impact factor: 3.584
Authors: Trecia A Wouldes; Linda L Lagasse; Marilyn A Huestis; Sheri Dellagrotta; Lynne M Dansereau; Barry M Lester Journal: Neurotoxicol Teratol Date: 2014-02-22 Impact factor: 3.763
Authors: Sabrina D Diaz; Lynne M Smith; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn A Huestis; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester Journal: J Pediatr Date: 2014-03-12 Impact factor: 4.406
Authors: Chris Derauf; Barry M Lester; Nurunisa Neyzi; Minal Kekatpure; Luis Gracia; James Davis; Kalpana Kallianpur; Jimmy T Efird; Barry Kosofsky Journal: Dev Neurosci Date: 2012-08-17 Impact factor: 2.984
Authors: Jean Twomey; Linda LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne Smith; Amelia Arria; Marilyn Huestis; Sheri DellaGrotta; Mary Roberts; Lynne Dansereau; Charles Neal; Barry Lester Journal: Am J Orthopsychiatry Date: 2013-01
Authors: Lynne M Smith; Sabrina Diaz; Linda L LaGasse; Trecia Wouldes; Chris Derauf; Elana Newman; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester Journal: Neurotoxicol Teratol Date: 2015-07-23 Impact factor: 3.763